Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Well-Being Champion Impact on Employee Engagement, Staff Satisfaction, and Employee Well-Being.

Wieneke KC, Egginton JS, Jenkins SM, Kruse GC, Lopez-Jimenez F, Mungo MM, Riley BA, Limburg PJ.

Mayo Clin Proc Innov Qual Outcomes. 2019 May 27;3(2):106-115. doi: 10.1016/j.mayocpiqo.2019.04.001. eCollection 2019 Jun.

2.

Marine omega-3 fatty acid intake and survival of stage III colon cancer according to tumor molecular markers in NCCTG Phase III trial N0147 (Alliance).

Song M, Ou FS, Zemla TJ, Hull MA, Shi Q, Limburg PJ, Alberts SR, Sinicrope FA, Giovannucci EL, Van Blarigan EL, Meyerhardt JA, Chan AT.

Int J Cancer. 2019 Jul 15;145(2):380-389. doi: 10.1002/ijc.32113. Epub 2019 Jan 28.

PMID:
30623420
3.

A Worksite Wellness Intervention: Improving Happiness, Life Satisfaction, and Gratitude in Health Care Workers.

Berkland BE, Werneburg BL, Jenkins SM, Friend JL, Clark MM, Rosedahl JK, Limburg PJ, Riley BA, Lecy DR, Sood A.

Mayo Clin Proc Innov Qual Outcomes. 2017 Oct 31;1(3):203-210. doi: 10.1016/j.mayocpiqo.2017.09.002. eCollection 2017 Dec.

4.

Chemoprevention of colorectal cancer: aspirin and beyond.

Limburg PJ.

Clin Adv Hematol Oncol. 2018 Aug;16(8):552-554. Review. No abstract available.

PMID:
30148827
5.

Physical Activity and Outcomes in Patients with Stage III Colon Cancer: A Correlative Analysis of Phase III Trial NCCTG N0147 (Alliance).

Phipps AI, Shi Q, Zemla TJ, Dotan E, Gill S, Goldberg RM, Hardikar S, Jahagirdar B, Limburg PJ, Newcomb PA, Shields A, Sinicrope FA, Sargent DJ, Alberts SR.

Cancer Epidemiol Biomarkers Prev. 2018 Jun;27(6):696-703. doi: 10.1158/1055-9965.EPI-17-0769. Epub 2018 Mar 21.

6.

Double-blind, randomized phase 3 trial of low-dose 13-cis retinoic acid in the prevention of second primaries in head and neck cancer: Long-term follow-up of a trial of the Eastern Cooperative Oncology Group-ACRIN Cancer Research Group (C0590).

Bhatia AK, Lee JW, Pinto HA, Jacobs CD, Limburg PJ, Rubin P, Arusell RM, Dunphy EP, Khandekar JD, Reiner SA, Baez-Diaz L, Celano P, Li S, Li Y, Burtness BA, Adams GL, Pandya KJ.

Cancer. 2017 Dec 1;123(23):4653-4662. doi: 10.1002/cncr.30920. Epub 2017 Aug 7.

7.

Bioactivity of Oral Linaclotide in Human Colorectum for Cancer Chemoprevention.

Weinberg DS, Lin JE, Foster NR, Della'Zanna G, Umar A, Seisler D, Kraft WK, Kastenberg DM, Katz LC, Limburg PJ, Waldman SA.

Cancer Prev Res (Phila). 2017 Jun;10(6):345-354. doi: 10.1158/1940-6207.CAPR-16-0286. Epub 2017 Apr 10.

8.

Family history of colorectal cancer and its impact on survival in patients with resected stage III colon cancer: results from NCCTG Trial N0147 (Alliance).

Jansson-Knodell CL, Foster NR, Sargent DJ, Limburg PJ, Thibodeau SN, Smyrk TC, Sinicrope FA, Jahagirdar B, Goldberg RM, Alberts SR.

J Gastrointest Oncol. 2017 Feb;8(1):1-11. doi: 10.21037/jgo.2016.12.13.

9.

Statistical controversies in clinical research: Value of adverse events relatedness to study treatment: analyses of data from randomized double-blind placebo-controlled clinical trials.

Le-Rademacher J, Hillman SL, Meyers J, Loprinzi CL, Limburg PJ, Mandrekar SJ.

Ann Oncol. 2017 Jun 1;28(6):1183-1190. doi: 10.1093/annonc/mdx043.

PMID:
28184420
10.

Cytotoxic T Cells and Granzyme B Associated with Improved Colorectal Cancer Survival in a Prospective Cohort of Older Women.

Prizment AE, Vierkant RA, Smyrk TC, Tillmans LS, Nelson HH, Lynch CF, Pengo T, Thibodeau SN, Church TR, Cerhan JR, Anderson KE, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2017 Apr;26(4):622-631. doi: 10.1158/1055-9965.EPI-16-0641. Epub 2016 Dec 15.

11.

Chemoprevention of colorectal cancer in individuals with previous colorectal neoplasia: systematic review and network meta-analysis.

Dulai PS, Singh S, Marquez E, Khera R, Prokop LJ, Limburg PJ, Gupta S, Murad MH.

BMJ. 2016 Dec 5;355:i6188. doi: 10.1136/bmj.i6188. Review.

12.

A Randomized Phase IIb Trial of myo-Inositol in Smokers with Bronchial Dysplasia.

Lam S, Mandrekar SJ, Gesthalter Y, Allen Ziegler KL, Seisler DK, Midthun DE, Mao JT, Aubry MC, McWilliams A, Sin DD, Shaipanich T, Liu G, Johnson E, Bild A, Lenburg ME, Ionescu DN, Mayo J, Yi JE, Tazelaar H, Harmsen WS, Smith J, Spira AE, Beane J, Limburg PJ, Szabo E; Cancer Prevention Network.

Cancer Prev Res (Phila). 2016 Dec;9(12):906-914. Epub 2016 Sep 22.

13.

Gastrointestinal Neoplasia: Current Perspectives and Emerging Frontiers.

Limburg PJ, Dixon DA.

Gastroenterol Clin North Am. 2016 Sep;45(3):xi-xii. doi: 10.1016/j.gtc.2016.06.001. No abstract available.

PMID:
27546849
14.

Common variants in the obesity-associated genes FTO and MC4R are not associated with risk of colorectal cancer.

Yang B, Thrift AP, Figueiredo JC, Jenkins MA, Schumacher FR, Conti DV, Lin Y, Win AK, Limburg PJ, Berndt SI, Brenner H, Chan AT, Chang-Claude J, Hoffmeister M, Hudson TJ, Marchand LL, Newcomb PA, Slattery ML, White E, Peters U, Casey G, Campbell PT.

Cancer Epidemiol. 2016 Oct;44:1-4. doi: 10.1016/j.canep.2016.07.003. Epub 2016 Jul 21.

15.

Alcohol consumption and colon cancer prognosis among participants in north central cancer treatment group phase III trial N0147.

Phipps AI, Shi Q, Limburg PJ, Nelson GD, Sargent DJ, Sinicrope FA, Chan E, Gill S, Goldberg RM, Kahlenberg M, Nair S, Shields AF, Newcomb PA, Alberts SR; Alliance for Clinical Trials in Oncology.

Int J Cancer. 2016 Sep 1;139(5):986-95. doi: 10.1002/ijc.30135. Epub 2016 May 9.

16.

Tumor eosinophil infiltration and improved survival of colorectal cancer patients: Iowa Women's Health Study.

Prizment AE, Vierkant RA, Smyrk TC, Tillmans LS, Lee JJ, Sriramarao P, Nelson HH, Lynch CF, Thibodeau SN, Church TR, Cerhan JR, Anderson KE, Limburg PJ.

Mod Pathol. 2016 May;29(5):516-27. doi: 10.1038/modpathol.2016.42. Epub 2016 Feb 26.

17.

Socioeconomic Inequalities in the Utilization of Colorectal Stents for the Treatment of Malignant Bowel Obstruction.

Okafor PN, Stobaugh DJ, Wong Kee Song LM, Limburg PJ, Talwalkar JA.

Dig Dis Sci. 2016 Jun;61(6):1669-76. doi: 10.1007/s10620-015-4019-8. Epub 2016 Jan 6.

PMID:
26738737
18.

Personalizing Aspirin Use for Targeted Breast Cancer Chemoprevention in Postmenopausal Women.

Bardia A, Keenan TE, Ebbert JO, Lazovich D, Wang AH, Vierkant RA, Olson JE, Vachon CM, Limburg PJ, Anderson KE, Cerhan JR.

Mayo Clin Proc. 2016 Jan;91(1):71-80. doi: 10.1016/j.mayocp.2015.10.018. Epub 2015 Dec 8.

19.

Tumor Budding in Colorectal Carcinoma: Confirmation of Prognostic Significance and Histologic Cutoff in a Population-based Cohort.

Graham RP, Vierkant RA, Tillmans LS, Wang AH, Laird PW, Weisenberger DJ, Lynch CF, French AJ, Slager SL, Raissian Y, Garcia JJ, Kerr SE, Lee HE, Thibodeau SN, Cerhan JR, Limburg PJ, Smyrk TC.

Am J Surg Pathol. 2015 Oct;39(10):1340-6. doi: 10.1097/PAS.0000000000000504.

20.

Aspirin Prevents Colorectal Cancer by Normalizing EGFR Expression.

Li H, Zhu F, Boardman LA, Wang L, Oi N, Liu K, Li X, Fu Y, Limburg PJ, Bode AM, Dong Z.

EBioMedicine. 2015 May 1;2(5):447-455.

21.

Association between body mass index and mortality for colorectal cancer survivors: overall and by tumor molecular phenotype.

Campbell PT, Newton CC, Newcomb PA, Phipps AI, Ahnen DJ, Baron JA, Buchanan DD, Casey G, Cleary SP, Cotterchio M, Farris AB, Figueiredo JC, Gallinger S, Green RC, Haile RW, Hopper JL, Jenkins MA, Le Marchand L, Makar KW, McLaughlin JR, Potter JD, Renehan AG, Sinicrope FA, Thibodeau SN, Ulrich CM, Win AK, Lindor NM, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2015 Aug;24(8):1229-38. doi: 10.1158/1055-9965.EPI-15-0094. Epub 2015 Jun 2.

22.

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology clinical practice guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology clinical practice guidelines.

Stoffel EM, Mangu PB, Limburg PJ; American Society of Clinical Oncology; European Society for Medical Oncology.

J Oncol Pract. 2015 May;11(3):e437-41. doi: 10.1200/JOP.2015.003665. Epub 2015 Mar 31. No abstract available.

PMID:
25829526
23.

Circulating Prostaglandin Biosynthesis in Colorectal Cancer and Potential Clinical Significance.

Li H, Liu K, Boardman LA, Zhao Y, Wang L, Sheng Y, Oi N, Limburg PJ, Bode AM, Dong Z.

EBioMedicine. 2015 Feb 1;2(2):165-171.

24.

Associations between Environmental Exposures and Incident Colorectal Cancer by ESR2 Protein Expression Level in a Population-Based Cohort of Older Women.

Tillmans LS, Vierkant RA, Wang AH, Samadder NJ, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2015 Apr;24(4):713-9. doi: 10.1158/1055-9965.EPI-14-0756. Epub 2015 Feb 3.

25.

Accuracy of urea breath test in Helicobacter pylori infection: meta-analysis.

Ferwana M, Abdulmajeed I, Alhajiahmed A, Madani W, Firwana B, Hasan R, Altayar O, Limburg PJ, Murad MH, Knawy B.

World J Gastroenterol. 2015 Jan 28;21(4):1305-14. doi: 10.3748/wjg.v21.i4.1305. Review.

26.

Hereditary colorectal cancer syndromes: American Society of Clinical Oncology Clinical Practice Guideline endorsement of the familial risk-colorectal cancer: European Society for Medical Oncology Clinical Practice Guidelines.

Stoffel EM, Mangu PB, Gruber SB, Hamilton SR, Kalady MF, Lau MW, Lu KH, Roach N, Limburg PJ; American Society of Clinical Oncology; European Society of Clinical Oncology.

J Clin Oncol. 2015 Jan 10;33(2):209-17. doi: 10.1200/JCO.2014.58.1322. Epub 2014 Dec 1.

27.

CT colonography for the detection of nonpolypoid adenomas: sensitivity assessed with restricted national CT colonography trial criteria.

Fidler JL, Zhang Z, Herman BA, Limburg PJ, Fletcher JG, Dachman A, Heiken JP, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon RG, Zimmerman P, Horton KM, Coakley K, Iyer RB, Hara A, Halvorsen RA Jr, Casola G, Yee J, Burgart LJ, Johnson CD.

AJR Am J Roentgenol. 2014 Dec;203(6):W614-22. doi: 10.2214/AJR.13.12356.

28.

HDAC8 and STAT3 repress BMF gene activity in colon cancer cells.

Kang Y, Nian H, Rajendran P, Kim E, Dashwood WM, Pinto JT, Boardman LA, Thibodeau SN, Limburg PJ, Löhr CV, Bisson WH, Williams DE, Ho E, Dashwood RH.

Cell Death Dis. 2014 Oct 16;5:e1476. doi: 10.1038/cddis.2014.422.

29.

Association between molecular subtypes of colorectal cancer and patient survival.

Phipps AI, Limburg PJ, Baron JA, Burnett-Hartman AN, Weisenberger DJ, Laird PW, Sinicrope FA, Rosty C, Buchanan DD, Potter JD, Newcomb PA.

Gastroenterology. 2015 Jan;148(1):77-87.e2. doi: 10.1053/j.gastro.2014.09.038. Epub 2014 Sep 30.

30.

AACR Cancer Progress Report 2014.

Arteaga CL, Adamson PC, Engelman JA, Foti M, Gaynor RB, Hilsenbeck SG, Limburg PJ, Lowe SW, Mardis ER, Ramsey S, Rebbeck TR, Richardson AL, Rubin EH, Weiner GJ.

Clin Cancer Res. 2014 Oct 1;20(19 Suppl):S1-S112. doi: 10.1158/1078-0432.CCR-14-2123. Epub 2014 Sep 16. No abstract available.

31.

Metformin does not reduce markers of cell proliferation in esophageal tissues of patients with Barrett's esophagus.

Chak A, Buttar NS, Foster NR, Seisler DK, Marcon NE, Schoen R, Cruz-Correa MR, Falk GW, Sharma P, Hur C, Katzka DA, Rodriguez LM, Richmond E, Sharma AN, Smyrk TC, Mandrekar SJ, Limburg PJ; Cancer Prevention Network.

Clin Gastroenterol Hepatol. 2015 Apr;13(4):665-72.e1-4. doi: 10.1016/j.cgh.2014.08.040. Epub 2014 Sep 15.

32.

Patient and tumor characteristics and BRAF and KRAS mutations in colon cancer, NCCTG/Alliance N0147.

Gonsalves WI, Mahoney MR, Sargent DJ, Nelson GD, Alberts SR, Sinicrope FA, Goldberg RM, Limburg PJ, Thibodeau SN, Grothey A, Hubbard JM, Chan E, Nair S, Berenberg JL, McWilliams RR; Alliance for Clinical Trials in Oncology.

J Natl Cancer Inst. 2014 Jun 12;106(7). pii: dju106. doi: 10.1093/jnci/dju106. Print 2014 Jul. Erratum in: J Natl Cancer Inst. 2014 Jul;106(7). doi:10.1093/jnci/dju228.

33.

Bisphosphonates in colorectal cancer.

Limburg PJ, Singh S.

Clin Adv Hematol Oncol. 2013 Jun;11(6):372-4. No abstract available.

PMID:
24472806
34.

Associations between cigarette smoking, hormone therapy, and folate intake with incident colorectal cancer by TP53 protein expression level in a population-based cohort of older women.

Tillmans LS, Vierkant RA, Wang AH, Jewel Samadder N, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2014 Feb;23(2):350-5. doi: 10.1158/1055-9965.EPI-13-0780. Epub 2013 Dec 16.

35.

Noncathartic CT colonography: Image quality assessment and performance and in a screening cohort.

Fletcher JG, Silva AC, Fidler JL, Cernigliaro JG, Manduca A, Limburg PJ, Wilson LA, Engelby TA, Spencer G, Harmsen WS, Mandrekar J, Johnson CD.

AJR Am J Roentgenol. 2013 Oct;201(4):787-94. doi: 10.2214/AJR.12.9225.

36.

Antidiabetic medications and the risk of colorectal cancer in patients with diabetes mellitus: a systematic review and meta-analysis.

Singh S, Singh H, Singh PP, Murad MH, Limburg PJ.

Cancer Epidemiol Biomarkers Prev. 2013 Dec;22(12):2258-68. doi: 10.1158/1055-9965.EPI-13-0429. Epub 2013 Sep 16. Review.

37.

Reply: To PMID 23220165.

Singh S, Singh AG, Murad MH, Limburg PJ.

Clin Gastroenterol Hepatol. 2013 Sep;11(9):1209-10. doi: 10.1016/j.cgh.2013.05.026. Epub 2013 Jun 2. No abstract available.

PMID:
23735446
38.

Associations between colorectal cancer molecular markers and pathways with clinicopathologic features in older women.

Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Gastroenterology. 2013 Aug;145(2):348-56.e1-2. doi: 10.1053/j.gastro.2013.05.001. Epub 2013 May 7.

39.

Associations between cigarette smoking status and colon cancer prognosis among participants in North Central Cancer Treatment Group Phase III Trial N0147.

Phipps AI, Shi Q, Newcomb PA, Nelson GD, Sargent DJ, Alberts SR, Limburg PJ.

J Clin Oncol. 2013 Jun 1;31(16):2016-23. doi: 10.1200/JCO.2012.46.2457. Epub 2013 Apr 1.

40.

Population pharmacokinetic model for cancer chemoprevention with sulindac in healthy subjects.

Berg AK, Mandrekar SJ, Ziegler KL, Carlson EC, Szabo E, Ames MM, Boring D, Limburg PJ, Reid JM; Cancer Prevention Network.

J Clin Pharmacol. 2013 Apr;53(4):403-12. doi: 10.1002/jcph.26. Epub 2013 Feb 22.

41.

Randomized phase II trial of sulindac for lung cancer chemoprevention.

Limburg PJ, Mandrekar SJ, Aubry MC, Ziegler KL, Zhang J, Yi JE, Henry M, Tazelaar HD, Lam S, McWilliams A, Midthun DE, Edell ES, Rickman OB, Mazzone P, Tockman M, Beamis JF, Lamb C, Simoff M, Loprinzi C, Szabo E, Jett J; Cancer Prevention Network.

Lung Cancer. 2013 Mar;79(3):254-61. doi: 10.1016/j.lungcan.2012.11.011. Epub 2012 Dec 20.

42.

Bisphosphonates are associated with reduced risk of colorectal cancer: a systematic review and meta-analysis.

Singh S, Singh AG, Murad MH, Limburg PJ.

Clin Gastroenterol Hepatol. 2013 Mar;11(3):232-9.e1. doi: 10.1016/j.cgh.2012.11.026. Epub 2012 Dec 4. Review.

PMID:
23220165
43.

Associations between intake of folate and related micronutrients with molecularly defined colorectal cancer risks in the Iowa Women's Health Study.

Razzak AA, Oxentenko AS, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Nutr Cancer. 2012;64(7):899-910. doi: 10.1080/01635581.2012.714833.

44.

A combination of esomeprazole and aspirin reduces tissue concentrations of prostaglandin E(2) in patients with Barrett's esophagus.

Falk GW, Buttar NS, Foster NR, Ziegler KL, Demars CJ, Romero Y, Marcon NE, Schnell T, Corley DA, Sharma P, Cruz-Correa MR, Hur C, Fleischer DE, Chak A, Devault KR, Weinberg DS, Della'Zanna G, Richmond E, Smyrk TC, Mandrekar SJ, Limburg PJ; Cancer Prevention Network.

Gastroenterology. 2012 Oct;143(4):917-26.e1. doi: 10.1053/j.gastro.2012.06.044. Epub 2012 Jul 11.

45.

The National CT Colonography Trial: assessment of accuracy in participants 65 years of age and older.

Johnson CD, Herman BA, Chen MH, Toledano AY, Heiken JP, Dachman AH, Kuo MD, Menias CO, Siewert B, Cheema JI, Obregon R, Fidler JL, Zimmerman P, Horton KM, Coakley KJ, Iyer RB, Hara AK, Halvorsen RA Jr, Casola G, Yee J, Blevins M, Burgart LJ, Limburg PJ, Gatsonis CA.

Radiology. 2012 May;263(2):401-8. doi: 10.1148/radiol.12102177. Epub 2012 Feb 23.

46.

Cigarette smoking and colorectal cancer risk by KRAS mutation status among older women.

Samadder NJ, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Am J Gastroenterol. 2012 May;107(5):782-9. doi: 10.1038/ajg.2012.21. Epub 2012 Feb 21.

47.

Postmenopausal hormone therapy and colorectal cancer risk in relation to somatic KRAS mutation status among older women.

Limburg PJ, Limsui D, Vierkant RA, Tillmans LS, Wang AH, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR.

Cancer Epidemiol Biomarkers Prev. 2012 Apr;21(4):681-4. doi: 10.1158/1055-9965.EPI-11-1168. Epub 2012 Feb 15.

48.

A population-based study of prevalence and adherence trends in average risk colorectal cancer screening, 1997 to 2008.

Sinicrope PS, Goode EL, Limburg PJ, Vernon SW, Wick JB, Patten CA, Decker PA, Hanson AC, Smith CM, Beebe TJ, Sinicrope FA, Lindor NM, Brockman TA, Melton LJ 3rd, Petersen GM.

Cancer Epidemiol Biomarkers Prev. 2012 Feb;21(2):347-50. doi: 10.1158/1055-9965.EPI-11-0818. Epub 2011 Dec 5.

49.

Postmenopausal hormone therapy and colorectal cancer risk by molecularly defined subtypes among older women.

Limsui D, Vierkant RA, Tillmans LS, Wang AH, Weisenberger DJ, Laird PW, Lynch CF, Anderson KE, French AJ, Haile RW, Harnack LJ, Potter JD, Slager SL, Smyrk TC, Thibodeau SN, Cerhan JR, Limburg PJ.

Gut. 2012 Sep;61(9):1299-305. doi: 10.1136/gutjnl-2011-300719. Epub 2011 Oct 24.

50.

Aspirin therapy for cancer: it is never too late.

Jankowski JA, Limburg PJ.

Br J Cancer. 2011 Oct 11;105(8):1105-6. doi: 10.1038/bjc.2011.373. No abstract available.

Supplemental Content

Loading ...
Support Center